DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)

DaShenLin Pharmaceutical Group Revenue

DaShenLin Pharmaceutical Group had revenue of 6.39B CNY in the quarter ending September 30, 2024, with 11.42% growth. This brings the company's revenue in the last twelve months to 26.54B, up 9.88% year-over-year. In the year 2023, DaShenLin Pharmaceutical Group had annual revenue of 24.53B with 15.45% growth.

• Revenue (ttm): 26.54B
• Revenue Growth: +9.88%
• P/S Ratio: 0.72
• Revenue / Employee: 583.72K
• Employees: 45,466
• Market Cap: 19.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	24.53B	3.28B	15.45%
Dec 31, 2022	21.25B	4.49B	26.78%
Dec 31, 2021	16.76B	2.18B	14.92%
Dec 31, 2020	14.58B	3.44B	30.89%
Dec 31, 2019	11.14B	2.28B	25.76%